Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial

By Andersen Anders Nyboe   Devroey Paul   for the MERIT Group  

Human Reproduction, Vol. 21, Iss. 12, 2006-12 ,pp. : 3217-3227

Oxford University Press

Access to resources Recommend Favorite

Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial

By Ye Hong   Huang Guoning   Pei Li   Zeng Pinghong   Luo Xiu  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 540-544

Informa Healthcare

Access to resources Recommend Favorite

Comparing highly purified hMG and rFSH in patients undergoing IVF

By Trew Geoffrey H.  

Human Reproduction, Vol. 22, Iss. 6, 2007-06 ,pp. : 1797-1798

Oxford University Press

Access to resources Recommend Favorite

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonistsa randomized study

By Bosch E.   Vidal C.   Labarta E.   Simon C.   Remohi J.   Pellicer A.  

Human Reproduction, Vol. 23, Iss. 10, 2008-10 ,pp. : 2346-2351

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon ® ) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP ® ) in a fixed-dose regimen in women undergoing ovarian stimulation

By Hoomans Eric H.M.  

Human Reproduction, Vol. 14, Iss. 10, 1999-10 ,pp. : 2442-2447

Oxford University Press

Access to resources Recommend Favorite